No math. No dosing decisions.
Beta Bionics (betabionics.com) earns a Brand Analyzer score of 81 out of 100, placing it in the Strong Brand tier among Healthcare brands, Technology brands. Among 2705 Healthcare brands analyzed, Beta Bionics ranks in the 91st percentile (category average 70, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 90/100, Digital Presence 100/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 94/100, AI Discoverability 86/100, Brand Authority 29/100.
Beta Bionics is a healthcare technology company headquartered in Concord that develops automated insulin delivery systems for people with diabetes. Its flagship product, the iLet Bionic Pancreas, integrates with continuous glucose monitors to automatically calculate and administer insulin doses, removing the need for manual carb counting or dosing calculations. The company positions its technology as a simplified alternative to traditional insulin pumps, aiming to reduce the daily burden of diabetes management through adaptive, data-driven automation.
| Brand Name | Beta Bionics |
|---|---|
| Domain | betabionics.com |
| Industry | Healthcare, Technology |
| Headquarters | Concord |
| Main Competitors | Insulet (Omnipod) (83/100), Tandem Diabetes Care (88/100), Medtronic Diabetes, Dexcom (84/100), Abbott (FreeStyle Libre) |
Moz Domain Authority 37/100 vs category average 32 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #954,306 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "No math. No dosing decisions. Just freedom to live." (Meta description: 9 words. OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram, YouTube, GitHub; no detected presence on LinkedIn - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Beta Bionics scores 42/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Beta Bionics has a limited AI-visibility profile at 42/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (63/100) and its weakest is visibility (24/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #954,306 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 37/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Beta Bionics from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is Beta Bionics?", Claude could identify the brand as of August 2026. Beta Bionics is a medical device company that developed the iLet Bionic Pancreas, an automated insulin delivery system for people with type 1 diabetes that uses an algorithm to adjust insulin dosing without requiring users to count carbs or manually calculate doses. Best known for The iLet Bionic Pancreas, an FDA-cleared automated insulin delivery system for type 1 diabetes.
When asked "Best brands similar to Beta Bionics?", Claude would recommend Beta Bionics as of August 2026. It's a legitimate and notable player in the automated insulin delivery space, often mentioned alongside Tandem and Insulet when discussing modern diabetes tech.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Beta Bionics's main competitors include Insulet (Omnipod) (83/100), Tandem Diabetes Care (88/100), Medtronic Diabetes, Dexcom (84/100), Abbott (FreeStyle Libre). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
Beta Bionics and Tandem Diabetes Care are competitors in Healthcare. Brand Analyzer scores Beta Bionics at 81/100 and Tandem Diabetes Care at 88/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to Beta Bionics include Insulet (Omnipod) (83/100), Tandem Diabetes Care (88/100), Medtronic Diabetes, Dexcom (84/100), Abbott (FreeStyle Libre). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
Beta Bionics has limited AI-search visibility, scoring 42/100 on Brand Analyzer's AI visibility composite (visibility 24, trust 50, recommendation 63). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Beta Bionics official site
Beta Bionics is headquartered in Concord. Beta Bionics operates in the Healthcare category.
Sources: Wikidata
Beta Bionics offers the iLet Bionic Pancreas, an automated insulin delivery system designed for people with diabetes who require insulin therapy. The device integrates with continuous glucose monitor (CGM) sensors to continuously track blood glucose levels and automatically calculates and delivers insulin doses, making 100% of dosing decisions without requiring manual carb counting or calculations from the user. The system is built with adaptive technology that learns and adjusts to each individual's insulin needs over time.
Sources: Beta Bionics official site
Beta Bionics scores 63/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Beta Bionics official site
Beta Bionics designs and manufactures automated insulin delivery technology for people with diabetes. Its core offering, the iLet Bionic Pancreas, integrates with leading continuous glucose monitor (CGM) sensors to continuously track blood sugar levels and automatically determine and deliver insulin doses. The system is built to learn and adapt to each user's individual insulin needs over time, eliminating the need for manual dosing decisions, carb counting, or math-based insulin calculations that are typically required with traditional insulin pumps.
Sources: Beta Bionics official site
Beta Bionics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Beta Bionics official site
Beta Bionics is a healthcare technology company that develops automated insulin delivery systems for people with diabetes. Its main product, the iLet Bionic Pancreas, is an insulin delivery device designed to automatically manage insulin dosing without requiring users to perform manual calculations such as carb counting. The company is headquartered in Concord and operates in the healthcare and technology sectors, focusing on making diabetes management simpler through adaptive, automated technology integrated with continuous glucose monitoring sensors.
Sources: Beta Bionics official site
Beta Bionics is known for developing the iLet Bionic Pancreas, an automated insulin delivery system that makes all insulin dosing decisions on behalf of the user. It is recognized for eliminating the need for carb counting and manual dosing calculations, distinguishing it from traditional insulin pumps that require more active user input. The system's integration with CGM sensors and its adaptive, self-learning dosing algorithm are central to its identity in the diabetes technology space.
Sources: Beta Bionics official site
Beta Bionics' products are used by people with diabetes who require insulin therapy and are looking for a simplified, automated alternative to manual insulin dosing and carb counting. This includes individuals who use traditional insulin pumps but want a system that reduces the mental and mathematical burden of daily diabetes management by automatically calculating and delivering insulin based on data from integrated continuous glucose monitor sensors.
Sources: Beta Bionics official site
Ranked closest to Beta Bionics: Blue Cross and Blue Shield (81/100), Bayer (81/100), Catalent (81/100), Checkr (81/100).
A step up - brands to learn from: Olay (91/100), eFax (91/100).
Category leader: Elsevier (96/100).